Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The spatially resolved transcriptome signatures of glomeruli in chronic kidney disease
Geremy Clair, Hasmik Soloyan, Paolo Cravedi, Andrea Angeletti, Fadi Salem, Laith Al-Rabadi, Roger E. De Filippo, Stefano Da Sacco, Kevin V. Lemley, Sargis Sedrakyan, Laura Perin
Geremy Clair, Hasmik Soloyan, Paolo Cravedi, Andrea Angeletti, Fadi Salem, Laith Al-Rabadi, Roger E. De Filippo, Stefano Da Sacco, Kevin V. Lemley, Sargis Sedrakyan, Laura Perin
View: Text | PDF
Research Article Nephrology

The spatially resolved transcriptome signatures of glomeruli in chronic kidney disease

  • Text
  • PDF
Abstract

Here, we used digital spatial profiling (DSP) to describe the glomerular transcriptomic signatures that may characterize the complex molecular mechanisms underlying progressive kidney disease in Alport syndrome, focal segmental glomerulosclerosis, and membranous nephropathy. Our results revealed significant transcriptional heterogeneity among diseased glomeruli, and this analysis showed that histologically similar glomeruli manifested different transcriptional profiles. Using glomerular pathology scores to establish an axis of progression, we identified molecular pathways with progressively decreased expression in response to increasing pathology scores, including signal recognition particle–dependent cotranslational protein targeting to membrane and selenocysteine synthesis pathways. We also identified a distinct signature of upregulated and downregulated genes common to all the diseases investigated when compared with nondiseased tissue from nephrectomies. These analyses using DSP at the single-glomerulus level could help to increase insight into the pathophysiology of kidney disease and possibly the identification of biomarkers of disease progression in glomerulopathies.

Authors

Geremy Clair, Hasmik Soloyan, Paolo Cravedi, Andrea Angeletti, Fadi Salem, Laith Al-Rabadi, Roger E. De Filippo, Stefano Da Sacco, Kevin V. Lemley, Sargis Sedrakyan, Laura Perin

×

Figure 1

Clinical features and histopathology of glomeruli from patients with AS, FSGS, and MN as well as individuals with nondiseased glomeruli.

Options: View larger image (or click on image) Download as PowerPoint
Clinical features and histopathology of glomeruli from patients with AS,...
(A–D) Representative histology micrographs from serially sectioned kidney biopsies from a 9-year-old patient with AS (no. 1 and 2; A); a 6-year-old patient without disease (no. 8; B); a 25-year-old patient with AS (no. 3), 21- and 25-year-old patients with FSGS (no. 4 and 5), 21- and 62-year-old patients with MN (no. 6 and 7) (C); and 56-year-old and approximately 40-year-old patients without disease (non-diseased; no. 9 and 10) (original magnification, ×20). Select glomeruli (the same glomeruli also analyzed by DSP) were assessed histopathologically. Blown up projections in B and D show higher-magnification (original magnification, ×20) images of the tissue sections from where the glomerular ROIs were selected for DSP. (E and F) H&E-stained histology slides of biopsy samples from patients with AS (no. 1–3), FSGS (no. 4 and 5), and MN (no. 6 and 7) and samples without disease (no. 8, 9, and 10) were scored by a kidney pathologist in a blinded manner. Dot plots depicting the glomerular pathology scores in kidney biopsies from AS (no. 1 and 2) and nondiseased control glomeruli (no. 8) (E), and patients with AS (no. 3), FSGS (no. 4 and 5), and MN (no. 7, 6) and nondiseased glomeruli (F). *P < 0.05; **P < 0.01; ****P < 0.0001. Data are shown as the mean ± SD.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts